HOPE FOR FIBROIDS

Doctors Info Web Directory

March 2005 OBGYN.net Outstanding Achievement Award presented to Hope For Fibroids Organization.
Fibroid Discussion Forum

Home
Mission
Doctor List
Languages
HFF Updates
Men & Family
Pregnancy
Patient Guides
Just the FAQs
Case/Analysis Comments
Contact Form
Contact Us
Media
Research

Bibliography
Book List
Insurance
Legislation
Other Sources

Site Map


Hope For Fibroids Poster (PDF)

To download Adobe Reader
 

 


Legislation Reform Needed Update:

Peer-Reviewed Publications

 1. Rothstein, A.M., Benedetto, J.D., Worthington-Kirsch, R.L., and Gefter, M.L. "Unique Determinants Associated with Hybridoma Proteins Expressing a Cross-Reactive Idiotype: Frequency Among Individual Immune Sera", J Immunol 1980; 125(5):1987-1992
 2. Worthington-Kirsch, R.L., Raptopoulos, V., and  Cohen, I.T.  "Sequential Bilateral Torsion of Normal Ovaries in a Child",  J Ultrasound Med 1986; 5:663-664
 3. Bartter, T., Irwin, R.S., Phillips, D.A., Benotti, J.R., and Worthington-Kirsch, R.L.  "Pulmonary Artery Pseudoaneurysm:  A Potential Complication of Pulmonary Artery Catheterization",  Arch Int Med 1988; 148:471-473
 4. Worthington-Kirsch, R.L., Hutchins, F.L.,, and Popky, G.L.  “Uterine Artery Embolization for the Management of Symptomatic Fibroids: Current Experience with 125 Patients and Follow-Up of Up to One Year” (abstract) Radiology 1998; 206(2):575
 5. Worthington-Kirsch, R.L., Hutchins, F.L., and Popky, G.L. “Uterine Artery Embolization for Management of Symptomatic Fibroids: Mid-Term Results with 175 Patients and Follow-up to 18 Months” (abstract)  Am J Roentgenol 1998; 170(Supp:4):34-35
 6. Worthington-Kirsch, R.L., Hutchins, F.L., and Popky, G.L. “Uterine Arterial Embolization for the Management of Leiomyomas: Quality of Life Assessment and Clinical Response”,  Radiology 1998; 208:625-629
 7. Berkowitz, R.P., Hutchins, F.L., and Worthington-Kirsch, R.L.  “Vaginal Expulsion of Submucosal Fibroids Following Uterine Artery Embolization: A Report of Three Cases”,  J Reprod Med 1999; 44:373-376
 8. Worthington-Kirsch, RL.  “Flow Redistribution During Uterine Artery Embolization for the Management of Symptomatic Fibroids” (Letter) J Vasc Interv Radiol 1999; 10(2):237-238
 9. Worthington-Kirsch, R.L., Hutchins, F.L., and Berkowitz, R.P.  “Regarding Sloughing of Fibroids After Uterine Artery Embolization” (letter)  J Vasc Interv Radiol 1999; 10:1135
10. Hutchins, F.L and Worthington-Kirsch, R.L. "GnRH Analogs and Uterine Artery Embolization" (letter),  J Am Assoc Gynecol Laparosc 1999; 6(3):367-368
11. Hutchins, F.L., Worthington-Kirsch, R.L., and Berkowitz, R.P. “Selective Uterine Artery Embolization as Primary Treatment for Symptomatic Leiomyomata Uteri: A Review of 305 Consecutive Cases”,  J Am Assoc Gynecol Laparosc 1999; 6(3):279-284
12. Walker, WJ and Worthington-Kirsch, RL. “Fatal Septicemia After Uterine Fibroid Embolisation” (letter), The Lancet 1999; 354(9191):1730
13. Worthington-Kirsch, R.L., Smith, S.J., and Berkowitz, R.P. “Transient Buttock Pain After Uterine Artery Embolisation for the Management of  Fibroids”,  Min Invas Ther & Allied Technol 1999; 8:425-427
14. Delaney, M.L., Worthington-Kirsch, R.L., Hutchins, F.L., and Berkowitz, R.P. “Uterine Artery Embolisation for the Management of Myomata in Patients without Complaints of Menorrhagia”,  Min Invas Ther & Allied Technol 1999; 8:455-458
15. Worthington-Kirsch RL, Walker WJ, Adler L, and Hutchins FL. “Anatomic Variation in the Uterine Arteries: A Cause of Failure of Uterine Artery Embolisation for the Management of Symptomatic Myomata”, Min Invas Ther & Allied Technol 1999; 8:397-402
16. Worthington-Kirsch RL, ,Hutchins FL, and Berkowitz, RP.  "Uterine Interstitial Gas after Uterine Artery Embolization: A Benign Finding",  J Interv Radiol 1999; 14:181-185
17. Worthington-Kirsch RL. “Regarding the Anatomy of the Uterine Artery” (letter),  Am J Roentgenol 2000; 174(1):258
18. Worthington-Kirsch, R.L. and Hutchins, F.L.  "Retained Myoma Fragment after LASH Procedure ‑ Case Report and Imaging Findings" (Letter), Clin Radiol 2001; 56:777-778
19. Worthington-Kirsch RL, Fueredi GA, Goodwin SC, Machan L, Niedzwiecki GA, Reidy JF, Spies JB, Walker WJ.  “Polyvinyl Alcohol Particle Size for Uterine Artery Embolization” (letter). Radiology 2001; 218:605-606
20. Spies JB, Benenati JF, Worthington-Kirsch RL.  “Initial Experience with Use of Tris-acryl Gelatin Microspheres for Uterine Artery Embolization for Leiomyomata.”,   J Vasc Interv Radiol 2001; 12:1059-1063
21. Worthington-Kirsch RL, Koller NE.  “Time Course of Pain After Uterine Artery Embolization for Fibroid Disease”,  Medscape Women’s Health e-Journal 2002
22. Worthington-Kirsch RL, Siskin GP.  “Uterine Artery Embolization for Symptomatic Myomata”;  J Intensive Care Med 2004:19:13-21
23. Worthington-Kirsch RL.  “Modified Monorail Technique for Insertion of Tunneled Hemodialysis Catheters” (Letter),  J Vasc Interv Radiol 2004; 15:303-304
24. Spies JB, Cooper JM, Worthington-Kirsch RL, Lipman JC, Mills BB, Benenati JF.  “Outcome of Uterine Embolization and Hysterectomy for Leiomyomas: Results of a Multicenter Study”;  Am J Ob Gyn 2004; 191:22-31
25. Worthington-Kirsch RL.  “Uterine Artery Embolization: State of the Art”  Sem Interv Radiol 2004; 21:37-42
26. Goldberg J, Burd I, Price FV, Worthington-Kirsch RL. “Leiomyosarcoma in a Pre-Menopausal Patient Following Uterine Artery Embolization”, Am J Obstet Gynecol 2004; 191:1733-1735
27. Myers E, Goodwin SC, Landow W, Mauro M, Peterson E, Pron G, Spies JB, Worthington-Kirsch RL. “Prospective Data Collection of a New Procedure by a Specialty Society: The FIBROID Registry”, Obstet Gynecol 2005; 106:44-51
28. Worthington-Kirsch RL. Spies JB, Myers E, Mulgund J, Mauro MA, Pron G, Peterson E, Goodwin SC, “The Fibroid Registry for Outcomes Data (FIBROID) for Uterine Artery Embolization”, Obst et Gynecol 2005; 106:52-59
29. Spies JB, Myers ER, Worthington-Kirsch RL, Mulgund J, Mauro M, Pron G, Peterson E, Goodwin SC, The Fibroid Registry for Outcomes Data (FIBROID) for Uterine Artery Embolization: Outcome from Therapy, In Press
30. Worthington-Kirsch RL, Robert AC, Iussich G, “Anti-Emetic Prophylaxis for Uterine Artery Embolization for the Treatment of Fibroids”, In Preparation

Other Publications

 1. Worthington-Kirsch, R.L.   "Placement of Two Titanium Greenfield Filters in a Patient with Duplication of the Infrarenal Inferior Vena Cava:  Case Report and Anatomical Considerations"; Technique Spotlight...A Close-up View of Interventional Medicine, Vol. VI, 1992, Boston Scientific Corporation
 2. Worthington-Kirsch, R.L.  Procedure Manual: Angiography and Interventional Radiology: Mercy Catholic Medical Center”  (In House Publication)
 3. Worthington-Kirsch, R.L.  “Interventionalists Offer Management Option for Uterine Fibroids”;  Women’s Imaging Report Diagnostic Imaging 21(3):47-49, March 1999 
 4. Worthington-Kirsch, RL.  Radiologists Play Vital Role in Dialysis Graft   Interventions”;  Diagnostic Imaging 21(7):61-65, July 1999
 5. Goodwin SC, Landow WJ, Matalon TAS, Mauro MA, Pomerantz P, Worthington-Kirsch RL.  “Opportunity and Responsibility: SCVIR’s Role with Uterine Artery Embolization” (Editorial)  JVIR 2000; 11:409-410
 6. Hutchins FL and Worthington-Kirsch RL.  “Embolotherapy for Myoma-Induced Menorrhagia”;  Obstetric and Gynecologic Clinics of North America 2000; 2:397-405
 7. Worthington-Kirsch RL.  “Embolisation of the Uterine Artery”;  Hospital Healthcare Europe 2000/2001: R-15-R-17
 8. Machan L, Goodwin SC, Worthington-Kirsch RL, Spies JA.  “Fibroid Embolization: Periprocedural Care”;  Seminars in Interventional Radiology 2000; 17:247-254
 9. Worthington-Kirsch RL.  “Building a Practice in Gynecologic Embolotherapy”;  Seminars in Interventional Radiology 2000; 17:263-270
10. Spies J, Niedzwiecki G, Goodwin S, Patel N, Andrews R, Worthington-Kirsch RL, Lippman J, Machan L, Sacks D, Sterling K, Lewis C.  “Training Standards for Physicians Performing Uterine Artery Embolization for Leiomyomata: Consensus Statement Developed by the Task Force of Uterine Artery Embolization and the Standards Division of the Society of Cardiovascular & Interventional Radiology - August 2000”;  J Vasc Interv Radiol 2001; 12:19-21
11. Worthington-Kirsch RL.  “Uterine Artery Embolization: State-of-the-Art and New Developments”;  Intervention 2000 4:35-38
12. Goodwin SC, Bonilla SM, Sacks D, Reed RA, Spies JB, Landow WJ, Worthington-Kirsch RL.  “Reporting Standards for Uterine Artery Embolization for the Treatment of Uterine Leiomyomata”;  J Vasc Interv Radiol 2001; 12:1011-1020
13. Worthington-Kirsch RL.  “Embolotherapy: Future Developments and Challenges”;  Private Hospital Healthcare Europe 2002: R35
14. Vedantham S, Sterling KM, Goodwin SC, Spies JB, Shlansky-Goldberg R, Worthington-Kirsch RL, Andrews RT, Hovsepian DM, Smith SJ, Chrisman HB.  “Uterine Fibroid Embolization: Preprocedure Assessment”;  Techniques in Vascular and Interventional Radiology 2002; 5:2-16
15. Worthington-Kirsch RL, Andrews RT, Siskin GP, Shlansky-Goldberg R, Lipman JC, Goodwin SC, Bonn J, Hovsepian DM.  “Uterine Fibroid Embolization: Technical Aspects”;  Techniques in Vascular and Interventional Radiology 2002; 5:17-34
16. Siskin GP, Bonn J, Worthington-Kirsch RL, Smith SJ, Shlansky-Goldberg R, Machan LS, Andrews RT, Goodwin SC, Hovsepian DM.  “Uterine Fibroid Embolization: Pain Management”; Techniques in Vascular and Interventional Radiology 2002; 5:35-43
17. Lipman JC, Smith SJ, Spies JB, Siskin GP, Machan LS, Bonn J, Worthington-Kirsch RL, Goodwin SC, Hovsepian DM.  “Uterine Fibroid Embolization: Follow-Up”; Techniques in Vascular and Interventional Radiology 2002; 5:44-55
18. Sterling KM, Vogelzang RL, Chrisman HB, Worthington-Kirsch RL, Machan LS, Goodwin SC, Andrews RT, Hovsepian DM, Smith SJ, Bonn J.  “Uterine Fibroid Embolization: Management of Complications”;  Techniques in Vascular and Interventional Radiology 2002; 5:56-66
19. Chrisman HB, Smith SJ, Sterling KM, Vogelzang RL, Bonn J, Andrews RT, Worthington-Kirsch RL, Goodwin SC, Lipman JC, Siskin GP, Hovsepian DM “Uterine Fibroid Embolization: Developing a Clinical Service”; Techniques in Vascular and Interventional Radiology 2002; 5:67-76
20. Worthington-Kirsch RL.  “The Uterine Artery Embolization Procedure - A Follow-Up” Today’s Harrisburg Woman,  May 2002, Page 36
21. Worthington-Kirsch RL.  “Health: Uterine Artery Embolization: An Effective Treatment for Fibroid Disease”;  Today’s Woman,  August 2002, Page 52
22. Worthington-Kirsch RL.  "Uterine Artery Embolization - This therapeutic option for treating fibroid disease has steadily gained acceptance due to its advantages over surgical therapies"; Endovascular Today, September 2004; http://www.evtoday.com/PDFarticles/0904/et0904_women.pdf
23. Andrews RT, Spies JB, Sacks D, Worthington-Kirsch RL, Niedzwiecki GA, Marx MV, Hovsepian DM, Miller DL, Siskin GP, Raabe RD, Goodwin SC, Min RJ, Bonn J, Cardella JF, Patel NH. “Patient Care and Uterine Artery Embolization for Leiomyomata”,  National Guideline Clearinghouse;  J Vasc Interv Radiol 2004 Feb;15(2 Pt 1):115-20. PubMed http://www.guidelines.gov/summary/summary.aspx?view_id=1&doc_id=5394
24. Worthington-Kirsch RL,“Uterine Artery Embolization”, Endovascular Today 2004; 3:21-26
25. Worthington-Kirsch RL, “Uterine Artery Embolization for Fibroid Disease is Not Experimental”, Cardiovasc Interv Radiol 2005; 28:148-149
26. Worthington-Kirsch RL, “Injection Sclerotherapy”, Seminars in Interventional Radiology 2005; 22:209-217
27. Worthington-Kirsch RL, “Uterine Artery Embolization for Fibroid Disease”, Review and ADVANCE for Imaging In Press
28. Siskin GP, Shlansky-Goldberg RD, Goodwin SC, Sterling K, Lipman JC, Nosher JL, Worthington-Kirsch RL, Chambers TP. "A Prospective Multicenter Comparative Study between Myomectomy and Uterine Artery Embolization with Polyvinyl Alcohol Microspheres: Long-term Clinical Outcomes in Patients with Symptomatic Uterine Fibroids. "  J Vasc Interv Radiol. 2006 Aug;17(8):1287-95.  Pubmed

Book Chapters

 1. Worthington-Kirsch RL, Scott ME,  Charnsanangavej C.  “Pelvic Embolotherapy”, (Chapter), Taveras JM and Ferrucci JT, Eds, Radiology: Diagnosis, Imaging, Intervention 2000 Edition, Lippincott, Williams & Wilkins, Philadelphia, PA, USA, 2000 (also available on CD-ROM)
 2. Worthington-Kirsch RL, Hughes LA.   “Uterine Artery Embolization - Vascular Anatomic Considerations and Procedure Techniques”;  Tulandi T (Editor) Uterine Fibroids: Embolization and Other Treatments Cambridge University Press,  Cambridge, UK, 2003.
 3. Worthington-Kirsch RL, Landow WJ.  “The Future of Fibroid Embolotherapy: A Radiological Perspective”;  Tulandi T (Editor), Uterine Fibroids: Embolization and Other Treatments,  Cambridge University Press, Cambridge, UK, 2003
 4. Hutchins, Francis L., Worthington-Kirsch RL.   "The Fibroid Book 2nd Edition - A Guide to Treating the Most Common Cause of Hysterectomy",  Chapter 6 - "A New Alternative:  Uterine Artery Embolization".
 5. Worthington-Kirsch RL, Uterine Artery Embolization for Fibroid Disease (Chapter), Van Sonnenberg E, McMullen W, Solbiati L, Eds, "Tumor Ablation: Principles and Practice", Springer Science + Business Media, New York, NY, USA, 2005

Other Media

 1. Worthington-Kirsch, RL and Hutchins, FL “Embolotherapy of Uterine Myomata” SCVIR Case Club, Case Reference No. CC-497-03. http://www.scvir.org   (password protected), April 1997
 2. Worthington-Kirsch, RL.   “Aortobifemoral Graft Thrombolysis and Stenting”;  SCVIR Case Club, Case Reference No. CC-797-08. http://www.scvir.org   (password protected), July 1997
 3. Worthington-Kirsch, RL.   “Ovarian Vein Embolization”;  SCVIR Case Club,  Case Reference No. CC-797-10. http://www.scvir.org   (password protected), July 1997
 4. Worthington-Kirsch, RL.   “Ovarian Vein Syndrome Diagnosed by CT Scan”; SCVIR Case Club, Case Reference No. CC-1298-03. http://www.scvir.org  (password protected), December 1998
 5. Worthington-Kirsch, RL.  Online Chat  - “Uterine Arterial Embolization: An Interventional Radiologist's Perspective”;  WebMed.com/Sapient Health Network, April 13, 1999
 6. Worthington-Kirsch, RL.   “The Doctor’s In”  (Live Call-In Radio Show), WWDB Radio (96.5 FM), Philadelphia. PA, October 3, 1999
 7. Worthington-Kirsch, RL.   “Gas Formation in the Uterus After Embolization of Fibroids”SCVIR Case Club, Case Reference No. CC-1199-06. http://www.scvir.org  (password protected), November 1999
 8. Worthington-Kirsch, RL.   “Severe Ovarian Vein Syndrome”;  SCVIR Case Club, Case Reference No. CC-1199-07. http://www.scvir.org (password protected), November 1999
 9. Worthington-Kirsch, RL.   “Polymethylmethacrylate (PMMA) Glue Fixation of Pathologic Fracture of the Humerus”;  SCVIR Case Club,  Case Reference No. CC-1299-06. http://www.scvir.org   (password protected), December 1999
10. Worthington-Kirsch, RL.   “Embolization of Parasitized Ovarian Arteries in a Woman with Symptomatic Fibroids”;  SCVIR Case Club, Case Reference No. CC-0100-07. http://www.scvir.org   (password protected), January 2000
11. Spies J, Niedzwiecki G, Goodwin S, Patel N, Andrews R, Worthington-Kirsch RL, Lipman J, Machan L, Sacks D, Sterling K, Lewis C.  “Training Standards for Physicians Performing Uterine Artery Embolization for Leiomyomata”;  SCVIR Training Standard. http://www.scvir.org
12. Worthington-Kirsch, RL.  “Family Talk”  (Live Call-In TV Show), Topic - “Focus on Fibroids”, CN8, Union, NJ, April 12, 2001
13. Worthington-Kirsch, RL.   “HealthCast”  (TV Medical News Show), Topic – “ Uterine Artery Embolization”,  CN8, Philadelphia,  PA,  April 27, 2003,  May 11, 2003,  May 25,  2003

Scientific Presentations

 1. “Initial Experience with Uterine Artery Embolization for the Management of Symptomatic Uterine Fibroids”Francis L. Hutchins, Jr, MD and R.L. Worthington-Kirsch, MD,  International Congress of Gynecologic Endoscopy - Sponsored by The American Association of Gynecologic Laparoscopists (Seattle, WA), September 26, 1997
 2. “Uterine Artery Embolization for the Management of Symptomatic Uterine Fibroids: Current Experience with 125 Patients with Follow-Up of up to One Year”;  R.L. Worthington-Kirsch, MD, F.L. Hutchins, Jr., MD, and G.L. Popky, MD, FACR, Radiologic Society of North America (Chicago, IL), December 2, 1997
 3. “Uterine Artery Embolization for Management of Symptomatic Fibroids: Mid-Term Results with 175 Patients and Follow-up to 18 Months”;  R.L. Worthington-Kirsch, MD, F.L. Hutchins, Jr., MD,  and G.L. Popky, MD American Roentgen Ray Society (San Francisco, CA), April 27, 1998
 4. "Outcomes Analysis of Initial Experience with Uterine Artery Embolization (UAE) for Treatment of Myomas"; F.L. Hutchins, Jr, MD,   R. L. Worthington-Kirsch, MD, The International Society for Gynecologic Endoscopy, Annual Regional Meeting "Uterine Leiomyoma", Amsterdam, The Netherlands, August 27-29, 1998
 5. “Anatomic Variations in the Uterine Arteries: A Cause of Failure of Uterine Artery Embolization for the Management of Symptomatic Fibroids”;  R.L. Worthington-Kirsch, MD The 1st International Symposium on Embolization of Uterine Myomata, The Society for Minimally Invasive Therapy, 10th International Conference, London, UK, September 3-5, 1998
 6. “Uterine Artery Embolization for the Management of Myomata in Patients without Complaints of Menorrhagia”;  R.L. Worthington-Kirsch, MD, M.L. Delaney, DO, F.L. Hutchins, Jr, MD, The 1st International Symposium on Embolization of Uterine Myomata The Society for Minimally Invasive Therapy, 10th International Conference London, UK, September 3-5, 1998
 7. “Experience with 200 Consecutive Cases of Uterine Artery Embolization for Management of Symptomatic Uterine Fibroids”;  F.L. Hutchins, Jr, MD, R.L. Worthington-Kirsch, MD, International Congress of Gynecologic Endoscopy, 27th Annual Meeting of the American Association of Gynecologic Laparoscopists, Atlanta, GA, November 11, 1998
 8. “Time Course of Pain after Uterine Artery Embolization for Fibroid Disease”; R.L. Worthington-Kirsch, MD and Koller NE,  The 2nd International Symposium on Embolization of Uterine Myomata, The Society for Minimally Invasive Therapy, 11th International Conference, Boston, MA, September 16-18, 1999
 9. “Amenorrhea after Uterine Artery Embolization”, Berkowitz RP, Hutchins FL, Worthington-Kirsch RL.  Global Congress of Gynecologic Endoscopy 28th Annual Meeting of the American Association of Gynecologic Endoscopists Las Vegas, NV, November 8-11, 1999
10. “Evaluation of Pain after Uterine Artery Embolization”, Worthington-Kirsch RL.  Biosphere Medical Investigators Meeting, San Diego, CA, March 28, 2000
11. “Initial US Experience with EmbospheresÔ for Embolization of Uterine Leiomyomata”; Spies JB, Benenati JF, Worthington-Kirsch RL.  Uterine Artery Embolization (UAE) Conference Emerging Interventional Therapies Weekend Society of CardioVascular & Interventional Radiology,  Washington, DC, October 13-14, 2000
12. “Comparison of Embosphere and PVA Embolization Agents in a Porcine Renal Model”, Levine A, Kim D, Termin P, Worthington-Kirsch RL.  Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2001 Annual Meeting and Postgraduate Course, Gothenburg, Sweden, September 22-26, 2001
13. “Uterine Artery Embolization (UAE) Using Embospheres: Initial Results of a Phase II Comparative Study”Spies JB, Cooper JM, Worthington-Kirsch RL, Lipman JC, Benenati JM, McLucas B.  Society of Cardiovascular & Interventional Radiology 27th Annual Scientific Meeting, Baltimore, MD, USA, April 6-11, 2002
14. “Uterine Artery Embolization for Leiomyomata using Embospheres: Interim Results of a Phase II Comparative Study”;  Worthington-Kirsch RL New Trends in Embolotherapy Symposium sponsored by Terumo and Biosphere Medical during the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2002 Annual Meeting and Postgraduate Course, Luzerne, Switzerland, October 7, 2002
15. “Outcome from Uterine Embolization and Hysterectomy for Treatment of Leiomyomas: Results of a Multi-Center Comparative Study”; Spies JB, Cooper JA, Worthington-Kirsch RL, Lipman JC, Mills B, Benenati JF.   Society of Interventional Radiology 28th Annual Scientific Meeting,  Salt Lake City, UT, March 27 - April 1, 2003
16. The CIRREF FIBROID Registry Writing Committee CIRREF FIBROID “Registry Procedural Data - How Is UAE Performed?”,  Worthington-Kirsch RL.  Society of Interventional Radiology 28th Annual Scientific Meeting, Salt Lake City, UT, March 27 - April 1, 2003
17. The CIRREF FIBROID Registry Writing Committee CIRREF FIBROID ‘Registry Procedural Data - Procedural Data and Short-Term Outcomes CIRSE 2003’, Worthington-Kirsch RL Antalya, Turkey, September 20-24, 2003
18. The CIRREF FIBROID Registry Writing Committee CIRREF FIBROID “Registry Procedural Data - Procedural Data and Short-Term Outcomes RSNA 2003”, Worthington-Kirsch RL.  Chicago, IL, USA, November 30 - December 5, 2003
19. “Anti-Emetic Prophylaxis for Uterine Artery Embolization RSNA 2003”,  Iussich G, Worthington-Kirsch RL, Roberts AC  Chicago, IL, USA, November 30 - December 5, 2003
20. The Fibroid Registry for Outcomes Data (FIBROID) for Uterine Artery Embolization: Procedural Outcomes and Short Term (30 Day) Results,  SIR 2005 New Orleans, LA,  March 31 -  April 5, 2005, Worthington-Kirsch RL, Spies JB, Myers E, Mulgund J, Mauro MA, Pron G, Peterson E, Goodwin SC

Research Projects

 1. Uterine Artery Embolization for the Management of Fibroid Disease IRB - 1997 – 1; 1/97 - 8/97.  Graduate Health Systems - City Avenue Hospital,  R.L. Worthington-Kirsch
 2. Uterine Artery Embolization for the Management of Fibroid Disease Ongoing Clinical Research,  9/96 – Present,  Graduate Health Systems - City Avenue Hospital (9/96 - 8/97), Roxborough Memorial Hospital (9/97 - Present), R.L. Worthington-Kirsch
 3. An Investigation of Steroids Use for Management of Pain Associated with Post Uterine Artery Embolization for Treatment of Symptomatic Leiomyomata Uteri (Fibroids), IRB Approved 11/98 - 3/99, Roxborough Memorial Hospital, Francis L. Hutchins, Jr., Robert L. Worthington-Kirsch, Nnaemeka M. Umerah
 4. Comparison of Conscious Sedation and Limited Spinal Anesthesia in Management of Pain After Uterine Artery Embolization for Fibroid Disease, 7/99 - 8/99, Roxborough Memorial Hospital, R.L. Worthington-Kirsch, N.E. Koller 
 5. Use of EmbosphereÔ for Uterine Artery Embolization for the Management of Fibroid Disease (Phase I Trial), Sponsored by Biosphere Medical, IRB Approved 1/00 - 1/03, Roxborough Memorial Hospital, R.L. Worthington-Kirsch 
 6. Use of EmbosphereÔ for Uterine Artery Embolization for the Management of Fibroid Disease (Phase II Trial), Sponsored by Biosphere Medical, IRB Approved  10/00 – Present, Roxborough Memorial Hospital, R.L. Worthington-Kirsch
 7. Clinical Investigation of the Contour Emboli PVA and FasTRACKER-325 Infusion Catheter for use in Uterine Artery Embolization for the Management of Uterine Fibroids, Sponsored by Boston Scientific/Medi-Tech, IRB Approved, 8/01 - Present Roxborough Memorial Hospital, R. L. Worthington-Kirsch
 8. Clinical Investigation of the Contour-SE PVA and FasTRACKER-325 Infusion Catheter for use in Uterine Artery Embolization for the Management of Uterine Fibroids, Sponsored by Boston Scientific/Medi-Tech, IRB Approved 8/02 - Present Roxborough Memorial Hospital, R. L. Worthington-Kirsch

Peer Review

 1. American Family Physician
 2. Journal of Vascular & Interventional Radiology - Distinguished Reviewer Award 2002, 2003, 2004
 3. American Journal of Obstetrics and Gynecology
 4. CardioVascular & Interventional Radiology
 5. Human Reproduction Journals
 6. Medical Science Monitor

Consulting Positions

 1. Boston Scientific - July 1998 - Present
 2. Biosphere Medical  - September 1999 - Present
 3. BioCure - March 2002 - Present
 4. Vascular Solutions - March 2004 - Present
 5. BioCompatibles/Terumo - September 2004 - Present

Speaker Boards 

1. Biosphere Medical
2. Boston Scientific
3. Terumo
4. VNUS

Invited Lectures

 1.

“Pelvic Ultrasound”, OB/GYN Grand Rounds, Philadelphia College of Osteopathic Medicine,  June 1, 1995